中文版 | English
题名

Patent landscape of platelet growth factor receptor and c-KIT targets

作者
通讯作者Zhang, Hai-Long
发表日期
2023-09-01
DOI
发表期刊
ISSN
2046-8954
EISSN
2046-8962
摘要
Type III receptor tyrosine kinase, e.g., PDGFR, are associated with various autoimmune diseases. To show the status of PDGFR and c-KIT targets, we performed the US patent analysis. The present study showed that the R & D of c-KIT target was much earlier than the R & D of PDGFR targets. Currently, the PDGFR-based target demonstrates more applications in the development of biological therapy. Our findings indicated that some inhibitors of c-KIT target contained sulfur elements or 1,3-diazine rings. The c-KIT target has more competitive edges for chemical drug discovery than the PDGFR target. c-KIT and PDGFR targets are currently preferable for drug discovery in autoimmune diseases. This study was the first to show R & D differentiation between PDGFR and c-KIT targets in drug development.
关键词
相关链接[来源记录]
收录类别
语种
英语
学校署名
其他
WOS研究方向
Pharmacology & Pharmacy
WOS类目
Pharmacology & Pharmacy
WOS记录号
WOS:001072870900001
出版者
来源库
Web of Science
引用统计
被引频次[WOS]:0
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/571836
专题理学院_化学系
作者单位
1.Cent Int Intellectual Property Baotou Co Ltd, Baotou 014030, Peoples R China
2.Southern Univ Sci & Technol, Coll Sci, Dept Chem, Shenzhen 518055, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Hai-Long,Kong, Qian. Patent landscape of platelet growth factor receptor and c-KIT targets[J]. PHARMACEUTICAL PATENT ANALYST,2023.
APA
Zhang, Hai-Long,&Kong, Qian.(2023).Patent landscape of platelet growth factor receptor and c-KIT targets.PHARMACEUTICAL PATENT ANALYST.
MLA
Zhang, Hai-Long,et al."Patent landscape of platelet growth factor receptor and c-KIT targets".PHARMACEUTICAL PATENT ANALYST (2023).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Zhang, Hai-Long]的文章
[Kong, Qian]的文章
百度学术
百度学术中相似的文章
[Zhang, Hai-Long]的文章
[Kong, Qian]的文章
必应学术
必应学术中相似的文章
[Zhang, Hai-Long]的文章
[Kong, Qian]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。